Kidney Cancer News

Up until a couple weeks ago, Christopher Cooper was a typical 10-year-old boy. A rough-and-tumble kid, he likes to spend his days playing football for the Milford Mustangs, messing around with his brothers, hanging out with friends, riding his bike.

I totally disagree with what the Senate and House are doing with health care. The federal government has no business being in the insurance business and it will cost the taxpayers trillions of dollars.

Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SHetA2, researchers tricked cancer cells into responding to new treatments and undergoing cell suicide.

With Antigenics back in the news after the EMEA officially recommended against approving the company's kidney cancer vaccine in Europe - followed by the subsequent withdrawal of the approval application by Antigenics - a few readers of VFC's Stock House have requested comment.

This report provides insight into the pipeline status of kidney cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.

World War II Veteran Jack Tagg is losing vision in his right eye. He suffers from macular degeneration, a progressive illness that causes blindness.

I'd happily set aside further discussion of cancer screening, if I could. But the story won't die.

Diana Hey Cauley, PharmD, BCOP Clinical Pharmacy Specialist, Genitourinary Medical Oncology Division of Pharmacy, University of Texas M.D. Anderson Cancer Center Houston, Texas US Pharm.

Thanksgiving is a time to be thankful for everything we have. This year, one eastern Iowa woman is thankful for a very simple thing.

Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use , the scientific committee of the European Medicines Agency , has formally adopted a negative opinion on the marketing authorization application for Oncophage as a treatment in earlier-stage, localized renal cell carcinoma .

Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort.

Nov 17, 2009 - AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from a Phase 1 clinical study evaluating its oral, triple VEGF receptor inhibitor tivozanib in combination with the mTOR inhibitor temsirolimus , a rapamycin pro-drug, ...

Annette Bailey's mind races and her tears flow as she sits in her Ford Probe that raw and dreary November night.

Quebec City, Canada, November 9, 2009 terna Zentaris Inc. , a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of ...

Ace fundraiser Doreen Stroud has had to give up raising money for the Royal United Hospital in Bath after 24 years because of ill health.

Over 880,000 African Americans died in just ten years in the 1990s because they lacked access to health insurance.

He hoped to "bring a little light and a little bit of solace for these families." But it was a little girl, Emma, that caught his eye -- and ours.

The American Society of Clinical Oncology released its report, Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention and Screening, an independent assessment of the most significant clinical cancer research studies of the past year, including 15 major advances.

It is said that "knowledge is power." Purist that I am, I must contend that use of knowledge is power; otherwise it is just potential power.

Hanna has conflicted emotions in the case of a murdered drug dealer when he learns his Navy Seal comrades are involved.